Want to see PRME full AI Analyst Report?
Prime Medicine, Inc. (PRME) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Pm577a | Wilson Disease, Wilson's Disease, Wilsons Disease | phase1AndPhase2 | Not Yet Recruiting | A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD) | Jul 24, 2026 | ― |
| Pm359 | Chronic Granulomatous Disease, Granulomatous Disease, Chronic | phase1AndPhase2 | Active Not Recruiting | A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants With p47phox Autosomal Recessive Chronic Granulomatous Disease (CGD ) | Jul 11, 2024 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Pm577a | phase1AndPhase2 | Wilson Disease, Wilson's Disease, Wilsons Disease | Not Yet Recruiting | A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD) | Jul 24, 2026 | ― |
| Pm359 | phase1AndPhase2 | Chronic Granulomatous Disease, Granulomatous Disease, Chronic | Active Not Recruiting | A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants With p47phox Autosomal Recessive Chronic Granulomatous Disease (CGD ) | Jul 11, 2024 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Prime Medicine, Inc. (PRME) have in its pipeline
Prime Medicine, Inc. PRME is currently developing the following drugs: Pm577a, Pm359. These drug candidates are in various stages of clinical development as the company works toward FDA approval.